Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

NCT00209222 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Mantle-Cell

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Cisplatinum
DRUG: Ara-C
DRUG: Dexamethasone
DRUG: BCNU
DRUG: Melphalan
DRUG: Etoposide
DRUG: G-CSF
PROCEDURE: chemotherapy: R-CHOP
PROCEDURE: chemotherapy: R-DHAP
PROCEDURE: chemotherapy: Dexa-BEAM
PROCEDURE: stem cell harvest
PROCEDURE: total body irradiation
PROCEDURE: high-dose chemotherapy: Cyclophosphamide
PROCEDURE: high-dose chemotherapy: Ara-C /Melphalan

Sponsor

European Mantle Cell Lymphoma Network

Collaborators

[object Object]
[object Object]